Literature DB >> 9774457

Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates.

C T Hua1, J R Gamble, M A Vadas, D E Jackson.   

Abstract

Stimulation of platelet aggregation leads to tyrosine phosphorylation of a number of receptors and signaling molecules including platelet endothelial cell adhesion molecule-1 (PECAM-1). In this report, we demonstrate that both protein-tyrosine phosphatases SHP-1 and SHP-2 physically associate with different kinetics of assembly with tyrosine-phosphorylated human PECAM-1 during integrin alphaIIbbeta3-mediated platelet aggregation. Peptido-precipitation analysis revealed that tyrosine-phosphorylated peptides encompassing residues 658-668 and 681-691 of PECAM-1 bound specifically to both protein-tyrosine phosphatases SHP-1 and SHP-2. We further show that the association of SHP-1 with PECAM-1 occurs through the direct interaction of the src homology region 2 domains of SHP-1 with two highly conserved phosphotyrosine binding motifs within PECAM-1 having the sequences NSDVQpY663TEVQV and DTETVpY686SEVRK (where pY represents phosphotyrosine). In vitro dephosphorylation experiments using phosphotyrosyl PECAM-1 peptides encompassing either Tyr-663 or Tyr-686 revealed induction of SHP-1 catalytic activity, suggesting that PECAM-1 serves as a SHP-1 substrate. Surface plasmon resonance studies reveal that recombinant SHP-2 binds PECAM-1 phosphopeptides with 5-fold higher affinity than recombinant SHP-1. These data suggest that in hematopoietic cells such as platelets, PECAM-1 cellular signaling is regulated by the selective recruitment and activation of two distinct protein-tyrosine phosphatases, SHP-1 and SHP-2, via a common immunoreceptor tyrosine-based inhibitory-like motif.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774457     DOI: 10.1074/jbc.273.43.28332

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis.

Authors:  C W Wong; G Wiedle; C Ballestrem; B Wehrle-Haller; S Etteldorf; M Bruckner; B Engelhardt; R H Gisler; B A Imhof
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

Review 2.  Active participation of endothelial cells in inflammation.

Authors:  Joan M Cook-Mills; Tracy L Deem
Journal:  J Leukoc Biol       Date:  2005-01-03       Impact factor: 4.962

3.  Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation.

Authors:  Geraldine Ferjoux; Frederic Lopez; Jean-Pierre Esteve; Audrey Ferrand; Eric Vivier; Frederic Vely; Nathalie Saint-Laurent; Lucien Pradayrol; Louis Buscail; Christiane Susini
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

4.  CD44: target for antiangiogenesis therapy.

Authors:  Horace M DeLisser
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

5.  Maintenance of murine platelet homeostasis by the kinase Csk and phosphatase CD148.

Authors:  Jun Mori; Zoltan Nagy; Giada Di Nunzio; Christopher W Smith; Mitchell J Geer; Rashid Al Ghaithi; Johanna P van Geffen; Silke Heising; Luke Boothman; Bibian M E Tullemans; Joao N Correia; Louise Tee; Marijke J E Kuijpers; Paul Harrison; Johan W M Heemskerk; Gavin E Jarvis; Alexander Tarakhovsky; Arthur Weiss; Alexandra Mazharian; Yotis A Senis
Journal:  Blood       Date:  2018-01-04       Impact factor: 22.113

Review 6.  PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis.

Authors:  Sunyoung Park; Christine M Sorenson; Nader Sheibani
Journal:  Clin Sci (Lond)       Date:  2015-08       Impact factor: 6.124

7.  Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity.

Authors:  Jamie R Privratsky; Cathy M Paddock; Oliver Florey; Debra K Newman; William A Muller; Peter J Newman
Journal:  J Cell Sci       Date:  2011-04-12       Impact factor: 5.285

8.  CD31 is a key coinhibitory receptor in the development of immunogenic dendritic cells.

Authors:  Marc Clement; Giulia Fornasa; Kevin Guedj; Sanae Ben Mkaddem; Anh-Thu Gaston; Jamila Khallou-Laschet; Marion Morvan; Antonino Nicoletti; Giuseppina Caligiuri
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

Review 9.  PECAM-1: conflicts of interest in inflammation.

Authors:  Jamie R Privratsky; Debra K Newman; Peter J Newman
Journal:  Life Sci       Date:  2010-06-10       Impact factor: 5.037

10.  Gender dependence for a subset of the low-abundance signaling proteome in human platelets.

Authors:  Ofer Eidelman; Catherine Jozwik; Wei Huang; Meera Srivastava; Stephen W Rothwell; David M Jacobowitz; Xiaoduo Ji; Xiuying Zhang; William Guggino; Jerry Wright; Jeffrey Kiefer; Cara Olsen; Nima Adimi; Gregory P Mueller; Harvey B Pollard
Journal:  Hum Genomics Proteomics       Date:  2010-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.